NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
January 3, 2006 • Volume 3 / Number 1 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Radiation Therapy for Early-Stage Breast Cancer Reduces Mortality

Director's Update
A Glimpse of Things to Come

Spotlight
Mice Show What Happens Before Tumors Spread

Cancer Research Highlights
Human Cells Develop Resistance to RNAi

Chest X-Rays Detect Early Lung Cancer

Health Insurance and Quality of Cancer Treatment

FDA Update
Sorafenib Approved for Advanced Kidney Cancer

Funding Opportunities

Featured Clinical Trial
Carnitine Supplementation for Cancer-Related Fatigue

Notes
Mackall Takes On New Appointment

NIH Review of Research Applications Expedited

Workshop Discusses Affinity Capture Resources in Proteomics

State Tobacco Prevention Programs Inadequately Funded

Community Update
NCI Issues Revised and Expanded Cancer Trends Progress Report

Bulletin Archive

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health (NIH) is available at http://calendar.nih.gov/
cgi-bin/calendar
.
Pilot-Scale Libraries for High-Throughput Screening (P41)
RFA-RM-06-003

Letter of Intent Receipt Dates: Jan. 27, Sept. 1, 2006. Application Receipt Dates: Feb. 22, Sept. 22, 2006.

This is a renewal of RFA-RM-05-014. This funding opportunity will use the P41 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3311. Inquiries: Dr. John M. Schwab - schwabj@nigms.nih.gov.

Innovative Technologies for Molecular Analysis of Cancer (R21, R33)
RFA-CA-07-001

Letter of Intent Receipt Dates: Jan. 23, April 26, 2006. Application Receipt Dates: Feb. 22, May 26, 2006.

This is a renewal of RFA-CA-06-002. This funding opportunity will use the R21 and R33 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3307. Inquiries: Dr. Gregory J. Downing - downingg@mail.nih.gov.

Application of Emerging Technologies for Cancer Research (R21, R21/R33, R33)
RFA-CA-07-002

Letter of Intent Receipt Dates: Jan. 23, April 26, 2006. Application Receipt Dates: Feb. 22, May 26, 2006.

This is a renewal of RFA-CA-06-003. This funding opportunity will use the R21 and R33 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3308. Inquiries: Dr. Gregory J. Downing - downingg@mail.nih.gov.

Innovations in Cancer Sample Preparation (R21, R33, R21/R33)
RFA-CA-07-003

Letter of Intent Receipt Dates: Jan. 23, April 26, 2006. Application Receipt Dates: Feb. 22, May 26, 2006.

This is a renewal of RFA-CA-06-004. This funding opportunity will use the R21 and R33 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3309. Inquiries: Dr. Gregory J. Downing - downingg@mail.nih.gov.

Advanced Proteomic Platforms and Computational Sciences for the NCI Clinical Proteomic Technologies Initiative (R01, R21, R21/R33)
RFA-CA-07-005

Letter of Intent Receipt Date: March 11, 2006. Application Receipt Date: April 11, 2006.

This funding opportunity will use the R01, R21, and R33 award mechanisms. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3310. Inquiries: Dr. Gregory J. Downing - downingg@mail.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov